Are you working on an innovative oncology pharmacy project, service evaluation, or research study? Here’s your chance to share it with a global audience! Submit your abstract(s) online by Friday,…
The BOPA Digital SACT Verification Passport team have been working hard behind the scenes to update the Passport content for all users. These updates have been actioned by Compassly and…
The 28th British Oncology Pharmacy Association (BOPA) Annual Conference, 3-5 October 2025, ICC Belfast Have you registered for the BOPA Annual Conference 2025? Don’t miss out on the Early Bird Rate, available…
BOPA is pleased to announce a new 3-part webinar series, delivered in collaboration with Covidence, to support members in understanding and engaging with systematic reviews in oncology pharmacy. This…
[This webinar was originally scheduled on Wednesday 30th July] Tuesday 19th August 2025 at 19:00 BST Click HERE to register The BOPA Education and Training Subcommittee would like…
REGISTRATION NOW OPEN We are delighted to inform you that the UK SACT Board Annual Conference will be held in London on Thursday 27th November 2025. The UK SACT Board (UKSB)…
Elaine Vickers, creator of the UTIC course, has just produced a second YouTube playlist, this time explaining the mechanism of action of various types of cancer treatments. You can find…
The NEONC CAT conference returns this year on the 8th of November, in Hull. As the UK’s only dedicated cancer associated thrombosis (CAT) conference, it presents a unique opportunity for…
The BOPA Immunotherapy Specialist Interest Group invites all BOPA members to complete this survey. This builds on our previous work exploring the known disparity across the UK with regards to…
As president of the International Society of Oncology Pharmacy Practitioners and co-chair of the UK SACT Board, BOPA Member Netty Cracknell is championing the role of oncology pharmacy in delivering…
Tuesday 19th August 2025 at 19:00 BST Click HERE to register The BOPA Education and Training Subcommittee would like to invite you to the E&T Webinar: Utilizing AI…
Hello All One of the pressing issues the BOPA Immunotherapy Specialist Advisory Group has been working over the past year, is addressing/improving the access to second line immunosuppressants for the…
